HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease.

AuthorsSatoshi Yamasaki, Jun Aoki, Jinichi Mori, Shohei Mizuno, Naoyuki Uchida, Kazuki Ohashi, Takahiro Fukuda, Kazuhiro Ikegame, Tetsuya Eto, Yukiyasu Ogawa, Masatsugu Tanaka, Michihiro Hidaka, Koji Iwato, Masashi Sawa, Tatsuo Ichinohe, Yoshinobu Kanda, Yoshiko Atsuta, Masamitsu Yanada, Shingo Yano, Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 55 Issue 1 Pg. 249-252 (01 2020) ISSN: 1476-5365 [Electronic] England
PMID30971777 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Topics
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Myeloid, Acute (therapy)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: